Different cell cycle modulation following treatment of human ovarian carcinoma cells with a new platinum(IV) complex vs cisplatin. (Q40129145)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Different cell cycle modulation following treatment of human ovarian carcinoma cells with a new platinum(IV) complex vs cisplatin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Lenka Švihálková Šindlerová

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jan Vondráček

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

8

Alois Kozubík

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Viktor Horváth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Karel Soucek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Olga Blanárová

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jirina Hofmanová

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Petr Sova

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

1 reference

23 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

435-443

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17520175%20AND%20SRC:MED&resulttype=core&format=json

Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex

31 December 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-007-9062-7

Cell cycle checkpoints: preventing an identity crisis

21 January 2018

1 reference

12 December 2020

Comparative anti-tumor efficacy of two orally administered platinum(IV) drugs in nude mice bearing human tumor xenografts

1 reference

12 December 2020

A novel indolocarbazole, ICP-1, abrogates DNA damage-induced cell cycle arrest and enhances cytotoxicity: similarities and differences to the cell cycle checkpoint abrogator UCN-01.

1 reference

12 December 2020

Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues

1 reference

12 December 2020

Signaling to p53: breaking the MDM2-p53 circuit

1 reference

12 December 2020

Platinum(IV) complex with adamantylamine as nonleaving amine group: synthesis, characterization, and in vitro antitumor activity against a panel of cisplatin-resistant cancer cell lines.

1 reference

12 December 2020

mdm2 expression is induced by wild type p53 activity

1 reference

12 December 2020

Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis

1 reference

12 December 2020

Pathways governing G1/S transition and their response to DNA damage

1 reference

12 December 2020

An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53

1 reference

12 December 2020

GADD45 induction of a G2/M cell cycle checkpoint

1 reference

12 December 2020

The protein kinase C inhibitor ilmofosine (BM 41 440) arrests cells in G2 phase and suppresses CDC2 kinase activation through a mechanism different from that of DNA damaging agents

1 reference

12 December 2020

High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.

1 reference

12 December 2020

Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches

1 reference

12 December 2020

WAF1, a potential mediator of p53 tumor suppression

1 reference

12 December 2020

Cisplatin: from DNA damage to cancer chemotherapy.

1 reference

12 December 2020

The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.

1 reference

12 December 2020

Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen

1 reference

12 December 2020

Platinum(IV) anticancer complexes.

1 reference

12 December 2020

Pharmacokinetics and tissue distribution of platinum in rats following single and multiple oral doses of LA-12 [(OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV)]

1 reference

12 December 2020

Single-dose pharmacokinetics of a novel oral platinum cytostatic drug ([OC-6-43]-bis[acetato][1-adamantylamine]amminedichloroplatinum [IV]) in pigs

1 reference

12 December 2020

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

1 reference

12 December 2020

Mdm2 promotes the rapid degradation of p53

1 reference

12 December 2020

Cell cycle perturbations of platinum derivatives on two ovarian cancer cell lines

1 reference

12 December 2020

Cellular and molecular determinants of cisplatin resistance

1 reference

12 December 2020

p21 is a universal inhibitor of cyclin kinases

1 reference

12 December 2020

Lipoxygenase inhibitors induce arrest of tumor cells in S-phase of the cell cycle.

1 reference

12 December 2020

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

12 December 2020

Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45

1 reference

12 December 2020

New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?

1 reference

12 December 2020

Review of platinum anticancer compounds.

1 reference

12 December 2020

Cell cycle changes associated with formation of Pt-DNA adducts in human ovarian carcinoma cells with different cisplatin sensitivity

1 reference

12 December 2020

Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.

1 reference

12 December 2020

Satraplatin: an orally available platinum analog for the treatment of cancer

1 reference

12 December 2020

Current status of platinum-based antitumor drugs

1 reference

12 December 2020

New platinum(IV) complex with adamantylamine ligand as a promising anti-cancer drug: comparison of in vitro cytotoxic potential towards A2780/cisR cisplatin-resistant cell line within homologous series of platinum(IV) complexes

1 reference

12 December 2020

Synthesis, characterization and DNA modification induced by a novel Pt(IV)-bis(monoglutarate) complex which induces apoptosis in glioma cells.

1 reference

12 December 2020

Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines

1 reference

12 December 2020

DNA damage checkpoints: implications for cancer therapy

1 reference

12 December 2020

Cell cycle and apoptosis

1 reference

12 December 2020

A role for mismatch repair in control of DNA ploidy following DNA damage

1 reference

12 December 2020

Preclinical anti-tumor activity of a new oral platinum(IV) drug LA-12.

1 reference

12 December 2020

Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells.

1 reference

12 December 2020

Cisplatin: mode of cytotoxic action and molecular basis of resistance

1 reference

12 December 2020

Molecular aspects of antitumor effects of a new platinum(IV) drug.

1 reference

12 December 2020